Press Releases

08.08.2022

Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology

07.28.2022

PFIZER REPORTS SECOND-QUARTER 2022 RESULTS

06.28.2022

Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus

06.24.2022

Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts

06.23.2022

Valneva and Pfizer Announce Closing of Equity Investment

06.23.2022

Pfizer Declares Third-Quarter 2022 Dividend

06.09.2022

Pfizer Completes Acquisition of ReViral

06.06.2022

Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.

03.11.2022

Pfizer Completes Acquisition of Arena Pharmaceuticals